Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | snurportin 1 | No references | |
Homo sapiens | karyopherin (importin) beta 1 | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0153 | 0.2838 | 0.2838 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0112 | 0.1496 | 0.2418 |
Echinococcus multilocularis | snurportin 1 | 0.0372 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.1496 | 0.1046 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0153 | 0.2838 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0153 | 0.2838 | 0.2838 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0153 | 0.2838 | 0.246 |
Echinococcus granulosus | geminin | 0.0205 | 0.4527 | 0.4527 |
Echinococcus granulosus | integrin alpha 3 | 0.0114 | 0.1545 | 0.1545 |
Schistosoma mansoni | integrin alpha | 0.0148 | 0.2678 | 0.2678 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.4527 | 0.4527 |
Echinococcus multilocularis | integrin alpha 3 | 0.0114 | 0.1545 | 0.1545 |
Toxoplasma gondii | PAN domain-containing protein | 0.0308 | 0.7909 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0153 | 0.2838 | 0.5 |
Toxoplasma gondii | PAN domain-containing protein | 0.0308 | 0.7909 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0153 | 0.2838 | 0.2838 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.1635 | 0.1193 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0153 | 0.2838 | 0.5 |
Onchocerca volvulus | 0.0153 | 0.2838 | 0.5 | |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0228 | 0.5306 | 0.5058 |
Schistosoma mansoni | hypothetical protein | 0.0372 | 1 | 1 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0148 | 0.2678 | 0.9096 |
Brugia malayi | Kringle domain containing protein | 0.0153 | 0.2838 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.4527 | 0.4527 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 0.2838 | 0.246 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0153 | 0.2838 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.4527 | 0.4527 |
Brugia malayi | Protein kinase domain containing protein | 0.0153 | 0.2838 | 1 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0372 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.4147 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 1.636 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.